We recently compiled a list of the Top 10 AI Stocks on Wall Street’s Radar Right Now. In this article, we are going to take a ...

Barry Bannister, Stifel chief equity strategist, joins CNBC's 'Squawk on the Street' to discuss market outlooks for 2025.

After PepGen (PEPG) announced initial clinical data from the five and ten mg/kg dose cohorts in the ongoing FREEDOM-DM1 Phase 1 trial ...

Stifel upgraded Saia (SAIA) to Buy from Hold with an unchanged price target of $524. With the less-than-truckload group de-rating on discussion ...

Truist Financial Corp trimmed its position in shares of Stifel Financial Corp. (NYSE:SF – Free Report) by 39.4% during the ...

Inflation probably isn't going back to 2% without a recession, according to Barry Bannister, Stifel's top stock strategist.

Cheniere Energy (NYSE:LNG – Free Report) had its price target increased by Stifel Nicolaus from $237.00 to $255.00 in a ...

Ahead of the company's report on Monday before the market open, shares are up more than 12% year to date, compared to the S&P ...

Fintel reports that on February 21, 2025, Stifel downgraded their outlook for Cheniere Energy Partners, L.P. - Limited ...

Neurogene Inc. (NASDAQ: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neu ...

As the flurry of executive orders continues to flow from the White House, leaving in its wake chaos and confusion across the ...

With Trevi poised to soon announce data from a trial of its Haduvio drug as a treatment for refractory chronic cough (RCC), ...